CGON vs EL · $4.74B cap vs rev $15.05B
CG Oncology, Inc. Common stock (CGON) versus Estee Lauder Companies Inc (EL) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
CGON does not have a complete income-statement cache yet.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
CGON currently screens at market cap $4.74B. EL currently screens at market cap $31.92B.
Not investment advice. Open the CGON and EL stock pages for the full models.
Not investment advice.